the number ( bmax ) and affinity ( kd ) of these binding sites changes under certain pathological conditions -- including a reduction in ischaemia and in spontaneous hypertension , an increase in the latter , at present , only demonstrated for the dihydropyridine binding sites .
C0030660
pathological conditions
C0022116
ischaemia